Please try another search
Chiesi USA, Inc., a specialty pharmaceutical company, engages in the research, development, production, and commercialization of products in the areas of cardiovascular, respiratory, neonatology, rare disease, and special care therapeutics to the healthcare community. Its products include CARDENE I.V., a nicardipine hydrochloride premixed injection; BETHKIS, a tobramycin inhalation solution; and CUROSURF, a poractant alfa intratracheal suspension solution. The company also provides PERTZYE, a pancrelipase delayed-release capsule; RETAVASE, a recombinant; ZYFLO, A zileuton tablet; and ZYFLO CR, a zileuton extended-release tablet. The company was formerly known as Cornerstone Therapeutics Inc. and changed its name to Chiesi USA, Inc. in April 2014. Chiesi USA, Inc. was founded in 1935 and is based in Cary, North Carolina. Chiesi USA, Inc. operates as a subsidiary of Chiesi Farmaceutici S.p.A.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review